Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

CLI Statement on Johnson & Johnson Vaccine: Abortion-Derived Cell Lines Used in Production Process

FOR IMMEDIATE RELEASE: March 4, 2021 | Contact: Prudence Robertson, [email protected], 240-672-2828

 

Vaccine Recipients Deserve Transparency, Information About Alternatives

 

 

Washington, D.C.  – In response to the U.S. Food and Drug Administration’s authorization of the Johnson & Johnson COVID-19 vaccine, Charlotte Lozier Institute (CLI), the research arm of Susan B. Anthony List (SBA List), issued the following statement:

“For many Americans, the approval of Johnson & Johnson’s vaccine raises renewed questions about the use of cells derived from elective abortions. Many leading vaccine candidates supported by Operation Warp Speed, including the approved vaccines produced by Pfizer/BioNTech and Moderna, do not use abortion-derived cell lines in their production. Unlike the majority of those candidates, Johnson & Johnson does use these cell lines in the production process.

“These decisions are disappointing, given the availability of uncontroversial alternatives already in use. They create an unnecessary dilemma for countless people weighing their options – but every vaccine recipient deserves to know. CLI remains committed to providing timely and accurate information so that individuals and families can make well-informed decisions.”

 

CLI’s analysis found that a majority of Warp Speed vaccine candidates did not use abortion-derived cell lines in their production. Several used abortion-derived cell lines in laboratory testing, or their use in testing could not be determined. CLI also just released an updated detailed chart on these and many other COVID-19 vaccine candidates.

 

Additional CLI resources related to COVID-19 and vaccines include:

 

CLI Vice President David Prentice and Director of Life Sciences Tara Sander Lee are available to discuss with media. To request an interview, please contact Prudence Robertson at [email protected] or 240-672-2828.

 

Charlotte Lozier Institute was launched in 2011 as the education and research arm of Susan B. Anthony List. CLI is a hub for research and public policy analysis on some of the most pressing issues facing the United States and nations around the world. The Institute is named for a feminist physician known for her commitment to the sanctity of human life and equal career and educational opportunities for women.  The 175th anniversary of Dr. Charlotte Denman Lozier’s birth occurred on March 16, 2019.

###

 

Latest Posts

March 25, 2024 Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case March 22, 2024 Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data March 21, 2024 Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

You Might Also Be Interested In

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

February 5, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image